These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21846259)

  • 1. Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors.
    El-Sakka AI
    Expert Opin Investig Drugs; 2011 Oct; 20(10):1305-9. PubMed ID: 21846259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review.
    Rambhatla A; Kovanecz I; Ferrini M; Gonzalez-Cadavid NF; Rajfer J
    Int J Impot Res; 2008; 20(1):30-4. PubMed ID: 17673932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
    Kaiho Y; Yamashita S; Arai Y
    Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penile rehabilitation following radical prostatectomy.
    Mulhall JP
    Curr Opin Urol; 2008 Nov; 18(6):613-20. PubMed ID: 18832948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of penile fibrosis: myth or reality.
    El-Sakka AI; Yassin AA
    J Androl; 2010; 31(4):324-35. PubMed ID: 19926883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats.
    Kovanecz I; Rambhatla A; Ferrini M; Vernet D; Sanchez S; Rajfer J; Gonzalez-Cadavid N
    Int J Impot Res; 2008; 20(2):202-12. PubMed ID: 17882231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats.
    Özden E; Öztürk B; Koşan M; Tezel GG; Aki FT; Gür S; Ergen A; Özen H
    Urology; 2011 Mar; 77(3):761.e1-7. PubMed ID: 21256544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.
    Hatzimouratidis K; Burnett AL; Hatzichristou D; McCullough AR; Montorsi F; Mulhall JP
    Eur Urol; 2009 Feb; 55(2):334-47. PubMed ID: 18986755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE5 inhibitors: targeting erectile dysfunction in diabetics.
    Francis SH; Corbin JD
    Curr Opin Pharmacol; 2011 Dec; 11(6):683-8. PubMed ID: 21924956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrergic function is lost but endothelial function is preserved in the corpus cavernosum and penile resistance arteries of men after radical prostatectomy.
    Martínez-Salamanca JI; La Fuente JM; Fernández A; Martínez-Salamanca E; Pepe-Cardoso AJ; Carballido J; Angulo J
    J Sex Med; 2015 Mar; 12(3):590-9. PubMed ID: 25529966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine signaling: good or bad in erectile function?
    Wen J; Xia Y
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):845-50. PubMed ID: 22423035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase type 5 in men with vasculogenic and post-radical prostatectomy erectile dysfunction: is there a molecular difference?
    Karakus S; Musicki B; Burnett AL
    BJU Int; 2018 Dec; 122(6):1066-1074. PubMed ID: 29888556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile hydraulics: maximizing inflow while minimizing outflow.
    Meldrum DR; Burnett AL; Dorey G; Esposito K; Ignarro LJ
    J Sex Med; 2014 May; 11(5):1208-20. PubMed ID: 24521101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience.
    Raina R; Pahlajani G; Agarwal A; Zippe CD
    Int J Impot Res; 2008; 20(2):121-6. PubMed ID: 17687391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penile rehabilitation with phosphodiesterase type 5 inhibitors after nerve-sparing radical prostatectomy: are we targeting the right patients?
    Castiglione F; Nini A; Briganti A
    Eur Urol; 2014 Apr; 65(4):673-4. PubMed ID: 24388439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update of PDE5 inhibitors for the treatment of ischemia-reperfusion].
    Hu YY; Wu ZG
    Zhonghua Nan Ke Xue; 2011 Sep; 17(9):842-6. PubMed ID: 21961251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of penile fibrosis.
    Gonzalez-Cadavid NF
    J Sex Med; 2009 Mar; 6 Suppl 3():353-62. PubMed ID: 19267860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism.
    Vignozzi L; Filippi S; Morelli A; Marini M; Chavalmane A; Fibbi B; Silvestrini E; Mancina R; Carini M; Vannelli GB; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1270-83. PubMed ID: 19210708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction.
    User HM; Hairston JH; Zelner DJ; McKenna KE; McVary KT
    J Urol; 2003 Mar; 169(3):1175-9. PubMed ID: 12576876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.